NEW YORK, Dec. 15, 2014 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) the ticker and exchange for Esperion Therapeutics, Inc. should read (Nasdaq:ESPR) (sted Nasdaq:EXPR).
CONTACT: Media Contacts: Joseph Christinat, Nasdaq +1.646.441.5121 Josh Machiz, Nasdaq +18.104.22.16814 Issuer & Investor Contact: Natasha Selzer, Nasdaq +1.301.978.8623
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.